Meeting
2019 Genitourinary Cancers Symposium
Biochemichal recurrence in prostate cancer after salvage surgery in correlation to the site of reccurrent disease.
Authors
David Pfister
University Hospital of Cologne, Cologne, Germany
David Pfister , Jasmin Pullankavumkal , Friederike Haidl , Axel Heidenreich
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B: Prostate Cancer; Urothelial Carcinoma; Penile, Urethral, Testicular, and Adrenal Cancers
Track
Urothelial Carcinoma,Prostate Cancer,Penile, Urethral, Testicular, and Adrenal Cancers
Sub Track
Prostate Cancer - Advanced Disease
Citation
J Clin Oncol 37, 2019 (suppl 7S; abstr 306)
DOI
10.1200/JCO.2019.37.7_suppl.306
Abstract #
306
Poster Bd #
D14
Abstract Disclosures
Similar Posters
Poster
2020 Genitourinary Cancers Symposium
Impact of 18F-fluciclovine PET on salvage radiotherapy plans for men with post-radical prostatectomy recurrence of prostate cancer.
First Author: Heather Ann Payne
Poster
2018 Genitourinary Cancers Symposium
68-Ga prostate-specific membrane antigen-PET as a diagnostic and clinical decision making tool in biochemical recurrences post-radical prostatectomy.
First Author: Janice Ser Huey Tan
Poster
2018 Genitourinary Cancers Symposium
68-Ga-PSMA-PET in lymph node staging in PSA recurrent prostate cancer-does the primary influence the result?
First Author: David Pfister
Poster
2013 Genitourinary Cancers Symposium
Current status and outcomes of salvage radiotherapy for patients with PSA recurrence after prostatectomy: A JROSG surveillance study.
First Author: Takashi Mizowaki